Literature DB >> 15220930

LATS1 tumour suppressor affects cytokinesis by inhibiting LIMK1.

Xiaolong Yang1, Kuanping Yu, Yawei Hao, Da-ming Li, Rodney Stewart, Karl L Insogna, Tian Xu.   

Abstract

LATS (large tumour suppressor) is a family of conserved tumour suppressors identified in Drosophila and mammals. Here we show that human LATS1 binds to LIMK1 in vitro and in vivo and colocalizes with LIMK1 at the actomyosin contractile ring during cytokinesis. LATS1 inhibits both the phosphorylation of cofilin by LIMK1 and LIMK1-induced cytokinesis defects. Inactivation of LATS1 by antibody microinjection or RNA-mediated interference in cells, or gene knockout in mice, abrogates cytokinesis and increases the percentage of multinucleate cells. Our findings indicate that LATS1 is a novel cytoskeleton regulator that affects cytokinesis by regulating actin polymerization through negative modulation of LIMK1.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15220930     DOI: 10.1038/ncb1140

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  78 in total

Review 1.  Understanding cytokinesis failure.

Authors:  Guillaume Normand; Randall W King
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

2.  Rb-dependent cellular senescence, multinucleation and susceptibility to oncogenic transformation through PKC scaffolding by SSeCKS/AKAP12.

Authors:  Shin Akakura; Peter Nochajski; Lingqiu Gao; Paula Sotomayor; Sei-ichi Matsui; Irwin H Gelman
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

3.  Phosphorylation of angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis.

Authors:  Xiaoming Dai; Peilu She; Fangtao Chi; Ying Feng; Huan Liu; Daqing Jin; Yiqiang Zhao; Xiaocan Guo; Dandan Jiang; Kun-Liang Guan; Tao P Zhong; Bin Zhao
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

4.  Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.

Authors:  Wei Li; Jonathan Cooper; Lu Zhou; Chenyi Yang; Hediye Erdjument-Bromage; David Zagzag; Matija Snuderl; Marc Ladanyi; C Oliver Hanemann; Pengbo Zhou; Matthias A Karajannis; Filippo G Giancotti
Journal:  Cancer Cell       Date:  2014-07-14       Impact factor: 31.743

Review 5.  Actin up for Hippo.

Authors:  Helena E Richardson
Journal:  EMBO J       Date:  2011-06-15       Impact factor: 11.598

Review 6.  Hippo Pathway: An Emerging Regulator of Craniofacial and Dental Development.

Authors:  J Wang; J F Martin
Journal:  J Dent Res       Date:  2017-07-12       Impact factor: 6.116

7.  G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene.

Authors:  Laura Regué; Fan Mou; Joseph Avruch
Journal:  Bioessays       Date:  2013-03-01       Impact factor: 4.345

8.  Aurora A kinase modulates actin cytoskeleton through phosphorylation of Cofilin: Implication in the mitotic process.

Authors:  Lisa Ritchey; Ratna Chakrabarti
Journal:  Biochim Biophys Acta       Date:  2014-08-01

9.  LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.

Authors:  Jiong Li; Xiaohong Chen; Xiangming Ding; Yingduan Cheng; Bin Zhao; Zhi-Chun Lai; Khalid Al Hezaimi; Razqallah Hakem; Kun-Liang Guan; Cun-Yu Wang
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

10.  Transcriptional activation of the Lats1 tumor suppressor gene in tumors of CUX1 transgenic mice.

Authors:  Rania Siam; Ryoko Harada; Chantal Cadieux; Robert Battat; Charles Vadnais; Alain Nepveu
Journal:  Mol Cancer       Date:  2009-08-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.